| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | disaccharide binding | 1.37e-06 | 7 | 69 | 3 | GO:0048030 | |
| GeneOntologyMolecularFunction | galactoside binding | 3.27e-06 | 9 | 69 | 3 | GO:0016936 | |
| GeneOntologyMolecularFunction | oligosaccharide binding | 4.32e-05 | 20 | 69 | 3 | GO:0070492 | |
| GeneOntologyMolecularFunction | interferon receptor activity | 1.17e-04 | 5 | 69 | 2 | GO:0004904 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 7.04e-04 | 310 | 69 | 6 | GO:0030246 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell degranulation | 1.49e-07 | 4 | 70 | 3 | GO:0043322 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell degranulation | 2.07e-06 | 8 | 70 | 3 | GO:0043321 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 1.07e-05 | 313 | 70 | 8 | GO:0098742 | |
| GeneOntologyBiologicalProcess | positive regulation of SMAD protein signal transduction | 1.36e-05 | 43 | 70 | 4 | GO:0060391 | |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell proliferation | 1.65e-05 | 15 | 70 | 3 | GO:2000562 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell activation | 1.65e-05 | 15 | 70 | 3 | GO:0032815 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte degranulation | 2.46e-05 | 17 | 70 | 3 | GO:0043301 | |
| GeneOntologyBiologicalProcess | natural killer cell degranulation | 2.95e-05 | 18 | 70 | 3 | GO:0043320 | |
| GeneOntologyBiologicalProcess | negative regulation of alpha-beta T cell proliferation | 3.49e-05 | 19 | 70 | 3 | GO:0046642 | |
| GeneOntologyBiologicalProcess | positive regulation of defense response to bacterium | 3.49e-05 | 19 | 70 | 3 | GO:1900426 | |
| GeneOntologyBiologicalProcess | regulation of T cell chemotaxis | 4.09e-05 | 20 | 70 | 3 | GO:0010819 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell differentiation | 4.77e-05 | 21 | 70 | 3 | GO:0032823 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 6.23e-05 | 63 | 70 | 4 | GO:0007157 | |
| GeneOntologyBiologicalProcess | regulation of defense response to bacterium | 9.20e-05 | 26 | 70 | 3 | GO:1900424 | |
| GeneOntologyBiologicalProcess | regulation of CD4-positive, alpha-beta T cell proliferation | 1.15e-04 | 28 | 70 | 3 | GO:2000561 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell proliferation | 1.42e-04 | 30 | 70 | 3 | GO:0035739 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte chemotaxis | 1.57e-04 | 31 | 70 | 3 | GO:1901623 | |
| GeneOntologyBiologicalProcess | positive regulation of regulatory T cell differentiation | 1.57e-04 | 31 | 70 | 3 | GO:0045591 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte differentiation | 1.72e-04 | 242 | 70 | 6 | GO:1902107 | |
| GeneOntologyBiologicalProcess | positive regulation of hemopoiesis | 1.72e-04 | 242 | 70 | 6 | GO:1903708 | |
| GeneOntologyBiologicalProcess | negative regulation of regulated secretory pathway | 1.73e-04 | 32 | 70 | 3 | GO:1903306 | |
| GeneOntologyBiologicalProcess | T cell chemotaxis | 1.90e-04 | 33 | 70 | 3 | GO:0010818 | |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-1 production | 2.29e-04 | 88 | 70 | 4 | GO:0032732 | |
| GeneOntologyBiologicalProcess | regulation of interleukin-1 production | 2.45e-04 | 165 | 70 | 5 | GO:0032652 | |
| GeneOntologyBiologicalProcess | regulation of SMAD protein signal transduction | 2.49e-04 | 90 | 70 | 4 | GO:0060390 | |
| GeneOntologyBiologicalProcess | cellular response to virus | 2.49e-04 | 90 | 70 | 4 | GO:0098586 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation in thymus | 2.68e-04 | 37 | 70 | 3 | GO:0033081 | |
| GeneOntologyBiologicalProcess | interleukin-1 production | 2.89e-04 | 171 | 70 | 5 | GO:0032612 | |
| GeneOntologyBiologicalProcess | natural killer cell differentiation | 2.90e-04 | 38 | 70 | 3 | GO:0001779 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 3.38e-04 | 40 | 70 | 3 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell activation | 3.38e-04 | 40 | 70 | 3 | GO:2000515 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 3.64e-04 | 41 | 70 | 3 | GO:0002716 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell migration | 3.64e-04 | 41 | 70 | 3 | GO:2000406 | |
| GeneOntologyBiologicalProcess | natural killer cell activation involved in immune response | 3.91e-04 | 42 | 70 | 3 | GO:0002323 | |
| GeneOntologyBiologicalProcess | positive regulation of macrophage activation | 3.91e-04 | 42 | 70 | 3 | GO:0043032 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 4.36e-04 | 187 | 70 | 5 | GO:0007156 | |
| GeneOntologyBiologicalProcess | negative regulation of exocytosis | 4.80e-04 | 45 | 70 | 3 | GO:0045920 | |
| GeneOntologyBiologicalProcess | positive regulation of oxidoreductase activity | 5.12e-04 | 46 | 70 | 3 | GO:0051353 | |
| GeneOntologyBiologicalProcess | SMAD protein signal transduction | 5.36e-04 | 110 | 70 | 4 | GO:0060395 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 5.45e-04 | 47 | 70 | 3 | GO:0001911 | |
| GeneOntologyBiologicalProcess | regulation of T-helper 17 type immune response | 5.45e-04 | 47 | 70 | 3 | GO:2000316 | |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-10 production | 5.80e-04 | 48 | 70 | 3 | GO:0032733 | |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | 6.13e-04 | 114 | 70 | 4 | GO:0045824 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte migration | 6.17e-04 | 49 | 70 | 3 | GO:2000403 | |
| GeneOntologyBiologicalProcess | regulation of regulatory T cell differentiation | 6.17e-04 | 49 | 70 | 3 | GO:0045589 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 6.33e-04 | 115 | 70 | 4 | GO:0090100 | |
| GeneOntologyBiologicalProcess | negative regulation of type II interferon production | 6.94e-04 | 51 | 70 | 3 | GO:0032689 | |
| GeneOntologyBiologicalProcess | negative regulation of alpha-beta T cell activation | 7.34e-04 | 52 | 70 | 3 | GO:0046636 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 7.34e-04 | 52 | 70 | 3 | GO:0031342 | |
| GeneOntologyBiologicalProcess | regulation of alpha-beta T cell proliferation | 7.77e-04 | 53 | 70 | 3 | GO:0046640 | |
| GeneOntologyBiologicalProcess | lymphocyte chemotaxis | 7.77e-04 | 53 | 70 | 3 | GO:0048247 | |
| GeneOntologyBiologicalProcess | regulatory T cell differentiation | 8.20e-04 | 54 | 70 | 3 | GO:0045066 | |
| GeneOntologyBiologicalProcess | regulation of T cell migration | 9.12e-04 | 56 | 70 | 3 | GO:2000404 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell proliferation | 1.06e-03 | 59 | 70 | 3 | GO:0046633 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | 1.10e-03 | 614 | 70 | 8 | GO:0010720 | |
| GeneOntologyBiologicalProcess | adherens junction organization | 1.17e-03 | 61 | 70 | 3 | GO:0034332 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell activation | 1.17e-03 | 61 | 70 | 3 | GO:0032814 | |
| GeneOntologyBiologicalProcess | negative regulation of defense response | 1.26e-03 | 353 | 70 | 6 | GO:0031348 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte degranulation | 1.28e-03 | 63 | 70 | 3 | GO:0043300 | |
| GeneOntologyBiologicalProcess | negative regulation of inflammatory response | 1.31e-03 | 239 | 70 | 5 | GO:0050728 | |
| GeneOntologyBiologicalProcess | macrophage activation | 1.32e-03 | 140 | 70 | 4 | GO:0042116 | |
| GeneOntologyBiologicalProcess | positive regulation by symbiont of entry into host | 1.32e-03 | 16 | 70 | 2 | GO:0075294 | |
| GeneOntologyBiologicalProcess | positive regulation of viral entry into host cell | 1.32e-03 | 16 | 70 | 2 | GO:0046598 | |
| GeneOntologyBiologicalProcess | T-helper 17 type immune response | 1.34e-03 | 64 | 70 | 3 | GO:0072538 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 1.46e-03 | 144 | 70 | 4 | GO:0045582 | |
| GeneOntologyBiologicalProcess | behavioral response to ethanol | 1.49e-03 | 17 | 70 | 2 | GO:0048149 | |
| GeneOntologyBiologicalProcess | negative regulation of response to biotic stimulus | 1.74e-03 | 151 | 70 | 4 | GO:0002832 | |
| GeneOntologyBiologicalProcess | toll-like receptor 2 signaling pathway | 1.87e-03 | 19 | 70 | 2 | GO:0034134 | |
| MousePheno | enhanced humoral immune response | 4.42e-05 | 17 | 58 | 3 | MP:0020155 | |
| MousePheno | abnormal T-helper 1 cell morphology | 4.53e-05 | 48 | 58 | 4 | MP:0002433 | |
| MousePheno | increased T-helper 1 cell number | 6.27e-05 | 19 | 58 | 3 | MP:0008086 | |
| MousePheno | increased spleen germinal center size | 1.13e-04 | 23 | 58 | 3 | MP:0008483 | |
| MousePheno | abnormal lymph node germinal center morphology | 1.13e-04 | 23 | 58 | 3 | MP:0008522 | |
| MousePheno | abnormal T-helper 1 cell number | 1.29e-04 | 24 | 58 | 3 | MP:0008085 | |
| MousePheno | abnormal lymph node secondary follicle morphology | 1.46e-04 | 25 | 58 | 3 | MP:0002346 | |
| Domain | - | 6.50e-08 | 95 | 70 | 7 | 2.60.120.200 | |
| Domain | ConA-like_dom | 1.59e-06 | 219 | 70 | 8 | IPR013320 | |
| Domain | Laminin_G | 2.51e-06 | 58 | 70 | 5 | IPR001791 | |
| Domain | LAM_G_DOMAIN | 1.21e-05 | 38 | 70 | 4 | PS50025 | |
| Domain | Laminin_G_2 | 1.49e-05 | 40 | 70 | 4 | PF02210 | |
| Domain | LamG | 2.19e-05 | 44 | 70 | 4 | SM00282 | |
| Domain | Gal-bind_lectin | 2.22e-05 | 15 | 70 | 3 | PF00337 | |
| Domain | Gal-bind_lectin | 2.22e-05 | 15 | 70 | 3 | SM00908 | |
| Domain | GALECTIN | 2.22e-05 | 15 | 70 | 3 | PS51304 | |
| Domain | Galectin_CRD | 2.22e-05 | 15 | 70 | 3 | IPR001079 | |
| Domain | GLECT | 2.22e-05 | 15 | 70 | 3 | SM00276 | |
| Domain | Interfer-bind | 6.11e-04 | 10 | 70 | 2 | PF09294 | |
| Domain | Interferon/interleukin_rcp_dom | 6.11e-04 | 10 | 70 | 2 | IPR015373 | |
| Domain | CADHERIN_1 | 8.57e-04 | 113 | 70 | 4 | PS00232 | |
| Domain | Cadherin | 8.57e-04 | 113 | 70 | 4 | PF00028 | |
| Domain | CADHERIN_2 | 8.85e-04 | 114 | 70 | 4 | PS50268 | |
| Domain | - | 8.85e-04 | 114 | 70 | 4 | 2.60.40.60 | |
| Domain | Tissue_fac | 8.92e-04 | 12 | 70 | 2 | PF01108 | |
| Domain | Tissue_factor | 8.92e-04 | 12 | 70 | 2 | IPR001187 | |
| Domain | FN3 | 9.02e-04 | 199 | 70 | 5 | PS50853 | |
| Domain | CA | 9.15e-04 | 115 | 70 | 4 | SM00112 | |
| Domain | Cadherin-like | 9.45e-04 | 116 | 70 | 4 | IPR015919 | |
| Domain | Cadherin | 1.01e-03 | 118 | 70 | 4 | IPR002126 | |
| Domain | FN3_dom | 1.12e-03 | 209 | 70 | 5 | IPR003961 | |
| Domain | EGF | 1.88e-03 | 235 | 70 | 5 | SM00181 | |
| Domain | EGF-like_dom | 2.42e-03 | 249 | 70 | 5 | IPR000742 | |
| Domain | FA58C | 2.78e-03 | 21 | 70 | 2 | SM00231 | |
| Domain | FA58C_3 | 2.78e-03 | 21 | 70 | 2 | PS50022 | |
| Domain | FA58C_1 | 2.78e-03 | 21 | 70 | 2 | PS01285 | |
| Domain | FA58C_2 | 2.78e-03 | 21 | 70 | 2 | PS01286 | |
| Domain | - | 3.28e-03 | 663 | 70 | 8 | 2.60.40.10 | |
| Domain | F5_F8_type_C | 3.62e-03 | 24 | 70 | 2 | PF00754 | |
| Domain | FA58C | 3.62e-03 | 24 | 70 | 2 | IPR000421 | |
| Domain | Cadherin_cytoplasmic-dom | 3.93e-03 | 25 | 70 | 2 | IPR000233 | |
| Domain | Cadherin_C | 3.93e-03 | 25 | 70 | 2 | PF01049 | |
| Domain | Ig-like_fold | 4.79e-03 | 706 | 70 | 8 | IPR013783 | |
| Domain | Catenin_binding_dom | 5.27e-03 | 29 | 70 | 2 | IPR027397 | |
| Domain | - | 5.27e-03 | 29 | 70 | 2 | 4.10.900.10 | |
| Domain | FIBRINOGEN_C_1 | 6.39e-03 | 32 | 70 | 2 | PS00514 | |
| Domain | Fibrinogen_a/b/g_C_dom | 6.39e-03 | 32 | 70 | 2 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 6.39e-03 | 32 | 70 | 2 | PS51406 | |
| Pubmed | Galectin-9 Is Critical for Mucosal Adaptive Immunity through the T Helper 17-IgA Axis. | 8.87e-09 | 3 | 73 | 3 | 29458010 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 19776007 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 26582205 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 9153289 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 33316546 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 18974023 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 9038233 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 23144904 | ||
| Pubmed | Impaired Gal-9 Dysregulates the PBMC-Induced Th1/Th2 Imbalance in Abortion-Prone Matings. | 8.87e-09 | 3 | 73 | 3 | 29651447 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 28704475 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 21146220 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 23836896 | ||
| Pubmed | Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes. | 8.87e-09 | 3 | 73 | 3 | 7890611 | |
| Pubmed | Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner. | 8.87e-09 | 3 | 73 | 3 | 22341088 | |
| Pubmed | Regulation of M1‑type and M2‑type macrophage polarization in RAW264.7 cells by Galectin‑9. | 8.87e-09 | 3 | 73 | 3 | 28990062 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 32380082 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 23667648 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 18579572 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 28877989 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 19800850 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 38987795 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 16990264 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 18005988 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 23585851 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 24477688 | ||
| Pubmed | A unique role for galectin-9 in angiogenesis and inflammatory arthritis. | 8.87e-09 | 3 | 73 | 3 | 29433546 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 37105392 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 36479526 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 23242525 | ||
| Pubmed | Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice. | 8.87e-09 | 3 | 73 | 3 | 19851072 | |
| Pubmed | The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes. | 8.87e-09 | 3 | 73 | 3 | 33923930 | |
| Pubmed | Alarmin function of galectin-9 in murine respiratory tularemia. | 8.87e-09 | 3 | 73 | 3 | 25898318 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 31937306 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 21426359 | ||
| Pubmed | Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases. | 8.87e-09 | 3 | 73 | 3 | 31969388 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 18282810 | ||
| Pubmed | Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia. | 8.87e-09 | 3 | 73 | 3 | 35241678 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 24083426 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 37279535 | ||
| Pubmed | The protective function of galectin-9 in liver ischemia and reperfusion injury in mice. | 8.87e-09 | 3 | 73 | 3 | 25931247 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 22627368 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 33153471 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 22052881 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 17560833 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 35643073 | ||
| Pubmed | Galectin-9 functionally impairs natural killer cells in humans and mice. | 8.87e-09 | 3 | 73 | 3 | 23408620 | |
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 38686388 | ||
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 22677125 | ||
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 19234217 | ||
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 35715604 | ||
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 19017954 | ||
| Pubmed | Galectin-9 Targets NLRP3 for Autophagic Degradation to Limit Inflammation. | 3.54e-08 | 4 | 73 | 3 | 33963043 | |
| Pubmed | Galectin-9: A novel promoter of atherosclerosis progression. | 3.54e-08 | 4 | 73 | 3 | 36459823 | |
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 33107565 | ||
| Pubmed | Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models. | 3.54e-08 | 4 | 73 | 3 | 29611821 | |
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 30763585 | ||
| Pubmed | Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2. | 3.54e-08 | 4 | 73 | 3 | 33727589 | |
| Pubmed | Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells. | 3.54e-08 | 4 | 73 | 3 | 19362679 | |
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 25578313 | ||
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 29844236 | ||
| Pubmed | Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response. | 3.54e-08 | 4 | 73 | 3 | 20463811 | |
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 32855403 | ||
| Pubmed | Galectin-3 mediates oligomerization of secreted hensin using its carbohydrate-recognition domain. | 3.54e-08 | 4 | 73 | 3 | 23657851 | |
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 18826117 | ||
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 24333756 | ||
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 38853593 | ||
| Pubmed | Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies. | 3.54e-08 | 4 | 73 | 3 | 24958847 | |
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 30120235 | ||
| Pubmed | [Expression of Galectin-9 and Tim-3 in lungs of mice with asthma]. | 3.54e-08 | 4 | 73 | 3 | 21575348 | |
| Pubmed | Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts. | 3.54e-08 | 4 | 73 | 3 | 18346632 | |
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 11839756 | ||
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 19670381 | ||
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 25450716 | ||
| Pubmed | The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. | 3.54e-08 | 4 | 73 | 3 | 16286920 | |
| Pubmed | Galectin-9 regulates the threshold of B cell activation and autoimmunity. | 3.54e-08 | 4 | 73 | 3 | 34369876 | |
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 33203936 | ||
| Pubmed | Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency. | 3.54e-08 | 4 | 73 | 3 | 22021615 | |
| Pubmed | 4.16e-08 | 17 | 73 | 4 | 9196007 | ||
| Pubmed | 8.84e-08 | 5 | 73 | 3 | 29242193 | ||
| Pubmed | 8.84e-08 | 5 | 73 | 3 | 28951537 | ||
| Pubmed | Galectin-9 mediates neutrophil capture and adhesion in a CD44 and β2 integrin-dependent manner. | 8.84e-08 | 5 | 73 | 3 | 34847625 | |
| Pubmed | 8.84e-08 | 5 | 73 | 3 | 22469568 | ||
| Pubmed | 8.84e-08 | 5 | 73 | 3 | 25158758 | ||
| Pubmed | C/EBPzeta (CHOP/Gadd153) is a negative regulator of LPS-induced IL-6 expression in B cells. | 8.84e-08 | 5 | 73 | 3 | 19782405 | |
| Pubmed | Embryonic implantation in galectin 1/galectin 3 double mutant mice. | 8.84e-08 | 5 | 73 | 3 | 9566950 | |
| Pubmed | 8.84e-08 | 5 | 73 | 3 | 26278059 | ||
| Pubmed | 8.84e-08 | 5 | 73 | 3 | 37352334 | ||
| Pubmed | 8.84e-08 | 5 | 73 | 3 | 33664349 | ||
| Pubmed | The glucose transporter 2 regulates CD8+ T cell function via environment sensing. | 8.84e-08 | 5 | 73 | 3 | 37884694 | |
| Pubmed | 8.84e-08 | 5 | 73 | 3 | 21385853 | ||
| Pubmed | 1.77e-07 | 6 | 73 | 3 | 28394331 | ||
| Pubmed | Tim3 binding to galectin-9 stimulates antimicrobial immunity. | 1.77e-07 | 6 | 73 | 3 | 20937702 | |
| Pubmed | 1.77e-07 | 6 | 73 | 3 | 8674632 | ||
| Pubmed | 1.77e-07 | 6 | 73 | 3 | 23296703 | ||
| Pubmed | Role of galectin-1 in the developing mouse olfactory system. | 3.09e-07 | 7 | 73 | 3 | 8873770 | |
| Pubmed | 4.93e-07 | 8 | 73 | 3 | 23751344 | ||
| Pubmed | 4.93e-07 | 8 | 73 | 3 | 31661141 | ||
| Pubmed | 4.93e-07 | 8 | 73 | 3 | 36883358 | ||
| Pubmed | 7.38e-07 | 9 | 73 | 3 | 21670307 | ||
| Pubmed | Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells. | 7.38e-07 | 9 | 73 | 3 | 25065622 | |
| Cytoband | 1p13 | 3.34e-04 | 17 | 73 | 2 | 1p13 | |
| GeneFamily | Galectins | 6.00e-06 | 15 | 44 | 3 | 629 | |
| GeneFamily | Fibronectin type III domain containing | 6.09e-04 | 160 | 44 | 4 | 555 | |
| GeneFamily | Cadherin related | 7.69e-04 | 17 | 44 | 2 | 24 | |
| GeneFamily | CD molecules|C2-set domain containing|Sialic acid binding Ig like lectins | 2.10e-03 | 28 | 44 | 2 | 745 | |
| Coexpression | GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_UP | 6.47e-08 | 195 | 72 | 8 | M8006 | |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_3DY_UP | 1.66e-06 | 131 | 72 | 6 | M40875 | |
| Coexpression | GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_DN | 1.88e-05 | 200 | 72 | 6 | M9262 | |
| Coexpression | LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX | 4.39e-05 | 141 | 72 | 5 | M39235 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | HIPK3 TANC2 FILIP1 RGL1 STOX2 DSG2 SBNO1 WDCP SLITRK4 TMPRSS2 REV3L IFI16 SOCS7 | 2.75e-06 | 818 | 71 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.33e-06 | 385 | 71 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_500 | 4.51e-05 | 388 | 71 | 8 | gudmap_developingLowerUrinaryTract_P1_bladder_500_J | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_1000 | HIPK3 FILIP1 EPS8 LDB3 COL12A1 DSG2 MAP3K20 TMPRSS2 POPDC2 REV3L IFI16 | 4.78e-05 | 772 | 71 | 11 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_J |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | HIPK3 TANC2 FILIP1 STOX2 DSG2 WDCP MAP3K20 TMPRSS2 POPDC2 IFI16 BRWD3 | 7.44e-05 | 811 | 71 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.54e-08 | 197 | 73 | 7 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | facs|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-07 | 171 | 73 | 6 | c9990bc041a632b2f7bbebbfe737772c423d7027 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.31e-07 | 181 | 73 | 6 | 7704f236831cffe4f2a75d4c461eb88b4177e206 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.50e-07 | 192 | 73 | 6 | d0fb6885f023d55a2b7984c99db9c6463258f788 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.45e-07 | 196 | 73 | 6 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.02e-05 | 175 | 73 | 5 | 11f49f00e000cbc137e3540a6d6805cde21d96e6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-05 | 176 | 73 | 5 | 4843af68f013732c28a8b8edad30d5fa0f2b084b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 176 | 73 | 5 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 176 | 73 | 5 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-05 | 176 | 73 | 5 | 95d5a4fdff1b9c715636684d22e06f8727ac0e7a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.05e-05 | 176 | 73 | 5 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-1|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.11e-05 | 178 | 73 | 5 | 51c59dabf2d7aef1b1964f6f766d5ec07ef90f5a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L3-6_PVALB_MFI2_(Chandelier_2)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.11e-05 | 178 | 73 | 5 | c982a73955c9c193bcab21d60d453afcc09cd586 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.14e-05 | 179 | 73 | 5 | 3b0f8781232e1d42b6f8913bc989a14b3f978e79 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-05 | 181 | 73 | 5 | 153709b4dd3d81e09f251fa8765b58bed1932fda | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.23e-05 | 182 | 73 | 5 | 9a68d3bd1cc9139de9e9e711c249d47ade826bb1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.23e-05 | 182 | 73 | 5 | d57d18732aa6fb7b2d430601568f9ba525ac6e3c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 185 | 73 | 5 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 185 | 73 | 5 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-05 | 187 | 73 | 5 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.44e-05 | 188 | 73 | 5 | 879de94924de978478696fc7838e05a4d795b905 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.44e-05 | 188 | 73 | 5 | 2db80767903703e7e0a1a37c598f7877a909ee94 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-05 | 189 | 73 | 5 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-05 | 189 | 73 | 5 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-05 | 190 | 73 | 5 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.52e-05 | 190 | 73 | 5 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 1.56e-05 | 191 | 73 | 5 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-05 | 191 | 73 | 5 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 192 | 73 | 5 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 192 | 73 | 5 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.68e-05 | 194 | 73 | 5 | 12a2c60303607b8b5812405ad216d0612c56c64b | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.68e-05 | 194 | 73 | 5 | 15060cc25baf49dd04d9c20499e28718610ef754 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-05 | 194 | 73 | 5 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-05 | 194 | 73 | 5 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-05 | 194 | 73 | 5 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.72e-05 | 195 | 73 | 5 | 3a30479857fc2805df92655c9599389559b1995d | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.72e-05 | 195 | 73 | 5 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.76e-05 | 196 | 73 | 5 | 29246378ffb1010fe6858da756ae3d13df2306ba | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-05 | 197 | 73 | 5 | bc6c530330907a5ec823cc243c8e9c9e340cfb9c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-05 | 197 | 73 | 5 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.80e-05 | 197 | 73 | 5 | ba6393671a980a1d439307601d18db70a1b1e1f3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-05 | 197 | 73 | 5 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-05 | 197 | 73 | 5 | 77fe092aae8f05fe137680506892d2f61071d6ea | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-05 | 198 | 73 | 5 | 79576525a10ed3e3a9d1608077cd16ecda23376f | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.89e-05 | 199 | 73 | 5 | 9a08c25bb4851ad4ac9db8916422280f71378c2c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.89e-05 | 199 | 73 | 5 | 18b6087863fda22e3e2a2167e7daeb347df1d95b | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.89e-05 | 199 | 73 | 5 | 2ed10c5e15c9d5ed0a8bea580842348d5698a07b | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SCUBE3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.94e-05 | 200 | 73 | 5 | 2441a36d363b799a4692aa697f969cda056c2d60 | |
| ToppCell | medial-mesenchymal-Airway_Smooth_Muscle|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.94e-05 | 200 | 73 | 5 | c1d9748aaae489d26e24602a5dcbe7f5fa9a5548 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SCUBE3-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.94e-05 | 200 | 73 | 5 | c7bca638229bd4fd2414171e73fa949e36a10a92 | |
| ToppCell | medial-mesenchymal-Airway_Smooth_Muscle-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.94e-05 | 200 | 73 | 5 | 6a5047018b12be3bc4b55a64d42e52e96c624003 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SCUBE3--L2-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.94e-05 | 200 | 73 | 5 | d841dbe2297c3bf62f49bae5921662cd6a47e5c2 | |
| ToppCell | medial-2-mesenchymal-Airway_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.94e-05 | 200 | 73 | 5 | 16b00eacbea4d75cf814803d3fc0b82c2b8c0a9c | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Calb1_Sst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.73e-05 | 146 | 73 | 4 | 10839a4fce2e62955a90592f927a6e0c6a84bbad | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 155 | 73 | 4 | 82e602f31981c6b48abff2a04b2ab5d26d4462a2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 155 | 73 | 4 | 979c1d53b435a82c57d16707eed8ba7346326866 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.52e-04 | 164 | 73 | 4 | 17d5b8bb7c015cf9f0d6e578a0d212eada39cb93 | |
| ToppCell | P28-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.67e-04 | 168 | 73 | 4 | 8c8dbdbc7053f34e4ca0c5067af502fbea109fc1 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.75e-04 | 170 | 73 | 4 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_4|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.75e-04 | 170 | 73 | 4 | 439167e44a1bd5ac8e1e457351dd202ec968db46 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.79e-04 | 171 | 73 | 4 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.79e-04 | 171 | 73 | 4 | 87d652afbb375f8ee50e5faecf6085630cd2163c | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-non-classical_monocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.83e-04 | 172 | 73 | 4 | 968d18ab8c3cdeb7936a2aa721a7f41525763863 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.83e-04 | 172 | 73 | 4 | 86f52f486d67217fc1b8443ab362c975df2974a4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.83e-04 | 172 | 73 | 4 | fb2df8fea6df5947165f13978f1d1006d15b60fd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.83e-04 | 172 | 73 | 4 | e38ebb216e4ddcd008148fcbaf709b4f3c83706a | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 1.87e-04 | 173 | 73 | 4 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-04 | 173 | 73 | 4 | fc2602b2ce051cd4c33957d7e3d041ff8a529883 | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-04 | 173 | 73 | 4 | f3f67531f72d6d52e19c7f1f2db1ab4026fb70da | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-04 | 173 | 73 | 4 | a40a52d8041d45dc3bef74fe55945ae07aa018d6 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-04 | 173 | 73 | 4 | 901b8e6909c1f3849906fad9cee17b8f0bab050d | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-04 | 173 | 73 | 4 | f0b4dd1cf41d6ee6abb0e1968b8b39f4fabebcb5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.87e-04 | 173 | 73 | 4 | d17e50dc400098374af626803dec1241ec566769 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.91e-04 | 174 | 73 | 4 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.91e-04 | 174 | 73 | 4 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.91e-04 | 174 | 73 | 4 | 99eb5e1aee136c7039e23b68a43a0fa3d775859f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.95e-04 | 175 | 73 | 4 | 90e29945aa861082c94bb4f331161adc3a6ef899 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.00e-04 | 176 | 73 | 4 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.00e-04 | 176 | 73 | 4 | e4b21fd6a5e0c5950f27c3e1868318e48330ae5e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-04 | 177 | 73 | 4 | 4943d040eee0f9dceaddc7498171281d170e271f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-04 | 177 | 73 | 4 | 3f2272b577c862dba8ccfb41184054bbd0ace6f5 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.04e-04 | 177 | 73 | 4 | c20df760b25caa772278397b02fc36521927cbfc | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L3-6_PVALB_MFI2_(Chandelier_2)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.04e-04 | 177 | 73 | 4 | 4f88ea4cfcfa8a9af5a14ab6f6be3b2aa015852e | |
| ToppCell | COVID-19-Heart-Lymph_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.04e-04 | 177 | 73 | 4 | 326fde0734ef0d7272693966d346ca479b9d8147 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.04e-04 | 177 | 73 | 4 | bde307e67ad8e48a5ff4c0827015f4688f6b3e46 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.08e-04 | 178 | 73 | 4 | 6ad46b0720298bcb927fd53468bb4ea0c199ad35 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.08e-04 | 178 | 73 | 4 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.08e-04 | 178 | 73 | 4 | c227da59dc7beb73f84405bf13356bdeb59d9338 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.13e-04 | 179 | 73 | 4 | e860dca9b28ac5af61804bfd729cd39257cdb352 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.13e-04 | 179 | 73 | 4 | 7954c0026754ab869b88ab7feb13c2f27d6e272d | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.17e-04 | 180 | 73 | 4 | 8ba9bba0c9fecf184a4332ba4585fb2439f68cd3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.17e-04 | 180 | 73 | 4 | e8841ef1239f9ee73ac4f4e11faca0742694f368 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.22e-04 | 181 | 73 | 4 | 08f44323bf71b6004a921bbc969c954c75feeb66 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.22e-04 | 181 | 73 | 4 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.27e-04 | 182 | 73 | 4 | e98ca9df33a1a81fc83ecf73d5141a14f2bc985c | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.27e-04 | 182 | 73 | 4 | dfde2d9950f445c6c936ac828f7210de87bb45ec | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 2.27e-04 | 182 | 73 | 4 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.27e-04 | 182 | 73 | 4 | 52274af3136d4fd4a495f5882618444661421f0f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-04 | 182 | 73 | 4 | 72e65a23cd36085bc880087d3cae92395de918a1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-04 | 182 | 73 | 4 | 05c167158815bf25d509df59ab386e1990712765 | |
| Disease | response to platinum based chemotherapy, cytotoxicity measurement | 5.06e-05 | 5 | 67 | 2 | EFO_0004647, EFO_0006952 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 1.41e-04 | 8 | 67 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | heart rate variability measurement, response to antipsychotic drug | 1.58e-04 | 46 | 67 | 3 | EFO_0008003, GO_0097332 | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 5.23e-04 | 15 | 67 | 2 | EFO_0004599, EFO_0007892 | |
| Disease | myeloid cell surface antigen CD33 measurement | 5.23e-04 | 15 | 67 | 2 | EFO_0008238 | |
| Disease | complement factor H-related protein 3 measurement | 6.01e-04 | 169 | 67 | 4 | EFO_0600056 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.02e-03 | 195 | 67 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | cognitive function measurement | 1.41e-03 | 1434 | 67 | 10 | EFO_0008354 | |
| Disease | eye colour measurement | 1.54e-03 | 218 | 67 | 4 | EFO_0009764 | |
| Disease | brain ischemia (biomarker_via_orthology) | 1.64e-03 | 102 | 67 | 3 | DOID:2316 (biomarker_via_orthology) | |
| Disease | C-C motif chemokine 7 measurement | 1.98e-03 | 29 | 67 | 2 | EFO_0008054 | |
| Disease | response to angiotensin receptor blocker | 2.12e-03 | 30 | 67 | 2 | EFO_0010735 | |
| Disease | Primary familial dilated cardiomyopathy | 2.12e-03 | 30 | 67 | 2 | cv:C0340427 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TSTRLQPQSTYIVGP | 76 | Q96KT6 | |
| QPQTVPVTFLSSRSY | 366 | Q9BZ76 | |
| AQITVSYPTPRSSQQ | 126 | Q8IX12 | |
| FPNTSVYPEATQRIT | 231 | P11308 | |
| QSQDTVIIAPPQYVT | 841 | Q68CP9 | |
| VIIAPPQYVTTSASN | 846 | Q68CP9 | |
| NYVKPPNVVNITSAR | 136 | Q6RI45 | |
| SPTYQTVPDFQRVQI | 106 | P23109 | |
| VIRSQYVPTPRTQQV | 461 | O94850 | |
| VSYSKQQNLPTVTSP | 161 | Q6ZUJ8 | |
| PNSVRSQVPALTTTY | 306 | Q8N7E2 | |
| LQQIPDVSPTGRYTT | 106 | Q9NTI2 | |
| YRRPPSITSQTSLQN | 371 | Q9NYB9 | |
| PVIRPIIATNTYQQV | 81 | Q9BTD8 | |
| PVSSYQRVTQTSPLQ | 286 | Q15434 | |
| TSITSTVLPPVYNQQ | 631 | Q9NZL6 | |
| SQPQSLIVTERVYAP | 956 | Q14126 | |
| QQTNRPVPVVYSLNT | 3646 | Q86XX4 | |
| QRTDPISTQTYTIPP | 1251 | Q5T1H1 | |
| RVVTTASIRPSVYQP | 396 | O75112 | |
| RTPQNTISIPYASQR | 246 | Q14439 | |
| QLSYISFQNPRAVPV | 141 | Q6DKI2 | |
| TIQLNVTYVPQNPTT | 226 | P20138 | |
| QLSYISFQNPRTVPV | 141 | Q3B8N2 | |
| QLSYISFQNPRTVPV | 141 | O00182 | |
| QYASQIPSSRQTQPV | 1691 | O60318 | |
| VTVRNKSNPLFQSPY | 2161 | Q9NYQ8 | |
| VSVQSLPRQSNYPVL | 211 | Q32MH5 | |
| YPQASAVTSQLQPVR | 471 | Q5T1M5 | |
| SPSYIQVTSPLSQQV | 106 | Q6ZTU2 | |
| SYSSNLPQVQPVREV | 46 | P31270 | |
| RQQAYIPTSVTSNPF | 1076 | Q9H422 | |
| YLPTNPTQEVQIIST | 61 | Q93033 | |
| RNLQPDTSYTVTVVP | 1901 | Q99715 | |
| IITTTPRPRVTYQVL | 686 | Q6ZTQ4 | |
| VQAPNIQIPSQETTY | 216 | P09172 | |
| YRIVTQTPQSPSQNM | 316 | P55283 | |
| QTYQIRTAPTSTIAP | 236 | P16220 | |
| PQNSVTVRVPQTTTY | 1091 | Q6VMQ6 | |
| PIKYQQITPVNQSRS | 621 | Q9NYL2 | |
| QRQYPVGTASLQTVP | 81 | Q3C1V0 | |
| QEQRQLPYPSEASTT | 406 | Q16666 | |
| TPVIPNSIVSSYNQT | 821 | Q9P267 | |
| PVALSNSTRPVVYQV | 51 | P38484 | |
| GPSSLAQPVQYSQIR | 291 | Q8N6P7 | |
| YSPQSLTDPQIRQIS | 1021 | Q9ULL0 | |
| VPRQNVPVINITYDS | 711 | Q12929 | |
| QTPVNPITGARVAQY | 16 | Q3B820 | |
| PPTESQVTYLRQIVT | 916 | Q8IY37 | |
| RVPAQQLYFTTPSNQ | 356 | Q16828 | |
| PSPYSPSSRVIQTLQ | 1156 | Q7Z5N4 | |
| LNVRQQPPSTTTFVL | 76 | A3KN83 | |
| QPQTVPVTFLSSRSY | 366 | Q96NU0 | |
| VSTYVTTNVSLIPPR | 166 | Q9BVX2 | |
| LSQIVSYQTRVPPLT | 326 | Q8IW52 | |
| LVSYVPSSQRQQEPT | 621 | Q9NRF2 | |
| PRGNVPVESQTTYTI | 396 | Q8IYX7 | |
| VPTPVRKYNSNANII | 1046 | Q7Z7B0 | |
| ATRDQLNIIVSYPPT | 291 | Q8NEB9 | |
| VTTNRTIQLNVSYPP | 226 | Q9Y286 | |
| PVRYQQETSVSQLPG | 1561 | Q9HCD6 | |
| APTPANRQISTYITV | 106 | Q9BYN7 | |
| QYAPRVLTQASNPVV | 51 | O15393 | |
| IPSVTRQVPSRKYTN | 666 | O60673 | |
| QPNNVLSTVQPVIIY | 311 | Q9NXZ1 | |
| PQTYFITPSLIRTNS | 141 | Q9P2F5 | |
| PTQVYIRTPSGEVQT | 351 | Q02086 | |
| YVVQVIVSQPVQNPT | 216 | Q8WUN7 | |
| FSTTPQTRIIQQPLI | 156 | Q12772 | |
| VSTIRQYPVSAQAPN | 511 | Q9H0E3 | |
| PLQSYSQVISRGQAP | 341 | Q9HBU9 | |
| TPVQLLYPVSRFSNV | 501 | O14512 | |
| IYSVIPSSVPNIQQI | 366 | Q9H6R7 | |
| INYIVRQPAPVQSQS | 551 | O15016 | |
| VRTIVNQISYTPQDP | 391 | Q6IA69 |